Oxalic Acid

Oxalic Acid

SCHEMBL5200567

Cc1cc(Cc2cnc[nH]2)c(C)c(NS(C)(=O)=O)c1.O=C(O)C(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 2/20 0.38
ADRA2A P08913 1/20 0.38
NR3C1 P04150 1/20 0.38
QPCT Q16769 1/20 0.38
QPCTL Q9NXS2 1/20 0.38
ALDH1A1 P00352 3/20 0.37
CYP3A4 P08684 1/20 0.37
GABRA1 P14867 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
GABRR1 P24046 1/20 0.37
GABRR2 P28476 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRB2 P47870 1/20 0.37
GABRA4 P48169 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HRH4 Q9H3N8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5204050 0.94 ADRA1A (0.42) ADRA1AADRA2ANR3C1QPCTQPCTL
SCHEMBL5201429 0.77 ADRA1A (0.48) ADRA1AADRA2ANR3C1ALDH1A1MAPT
SCHEMBL5200584 0.74 ADRA2A (0.32) ADRA1AADRA2A
SCHEMBL5206471 0.71 ADRA2A (0.54) ADRA1AADRA2AALDH1A1CYP3A4MAPT
SCHEMBL7101637 0.70 NR3C1 (0.39) NR3C1PTGS1
SCHEMBL5203578 0.70 ADRA1A (0.53) ADRA1AADRA2ACYP3A4L3MBTL1MAPT
SCHEMBL5200544 0.67 ADRA1A (0.48) ADRA1AADRA2ANR3C1CYP3A4TSHR
Hydrochloric Acid SCHEMBL5201568 0.66 ADRA1A (0.47) ADRA1AADRA2ANR3C1CYP3A4TSHR
SCHEMBL31253907 0.63 ADRA1D (0.50) ADRA1AADRA2AALDH1A1CYP3A4GABRA1
SCHEMBL17922097 0.62 HRH3 (0.61) QPCTQPCTLALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP disclosed